Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
September 09, 2024 15:50 ET
|
Enovis Corporation
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the...
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
September 05, 2024 08:00 ET
|
Enovis Corporation
Wilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology company, announced today it will unveil its new Tarsoplasty Percutaneous Lapidus...
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
August 20, 2024 08:00 ET
|
Enovis Corporation
WILMINGTON, DE, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, announced today the expansion of its EMPOWR Revision Knee™ system to...
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
August 19, 2024 08:00 ET
|
Enovis Corporation
Wilmington, DE, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, proudly unveils its Scandinavian Total Ankle Replacement (STAR®...
Enovis to Participate in Upcoming Investor Conferences
August 12, 2024 16:10 ET
|
Enovis Corporation
Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces Second Quarter 2024 Results
August 07, 2024 06:00 ET
|
Enovis Corporation
Continued strong momentum with second-quarter sales growth of 23% on a reported basis and strong adjusted margin expansionReported second-quarter net loss from continuing operations of $0.34 per share...
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
July 25, 2024 06:00 ET
|
Enovis Corporation
Wilmington, DE, July 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced a change in the scheduling of its upcoming...
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
July 16, 2024 07:00 ET
|
Enovis Corporation
Wilmington, DE, July 16, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
July 12, 2024 08:00 ET
|
Enovis Corporation
AUSTIN, TX, July 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a leading innovator in shoulder arthroplasty systems that help improve quality of life and restore movement, introduced today the...
Enovis to Participate in Upcoming Investor Conferences
May 10, 2024 06:00 ET
|
Enovis Corporation
Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate...